Microbion Corporation vs Pulmocide
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases
16 employees · est. 2000 · Bozeman, United States
Pulmocide
Developing best-in-class inhaled medicines for targeted treatment of life-threatening respiratory diseases
25 employees · est. 2013 · London, United Kingdom
Microbion Corporation is the older company (2000 vs 2013).
Side-by-Side Comparison
| Metric | Microbion Corporation | Pulmocide |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2013 |
| Headquarters | ||
| Headquarters | Bozeman, United States | London, United Kingdom |
| Employees | ||
| Employees | 16 | 25 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Venture round | Series C |
| Total Funding | ||
| Total Funding | Not tracked yet | $194.90M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 5 |
| Services | ||
| Services | Not tracked yet | Development of Novel Inhaled Medicines, Clinical Development of Opelconazole, Treatment for Invasive Pulmonary Aspergillosis, Research on Aspergillus-related Conditions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Invasive Pulmonary Aspergillosis, Healthcare Providers, Medical Researchers, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | PharmaceuticalsTherapeuticsDrug DevelopmentClinical-stage BiotechnologyMicrobial Biofilm PreventionChronic Lung Diseases +9 | BiopharmaceuticalsRespiratory DiseasesInhaled MedicinesFungal InfectionsPulmonary AspergillosisLung Transplant +5 |
| Website | ||
| Website | microbioncorp.com | pulmocide.com |
About Microbion Corporation
Microbion Corporation is a clinical-stage pharmaceutical company focusing on developing therapeutic compounds for rare and serious diseases. The company's lead drug candidate, pravibismane, has received substantial support, totaling over $21 million in grants from the Cystic Fibrosis Foundation, NIH...
About Pulmocide
Pulmocide, a biopharmaceutical company founded in 2013 and based in the United Kingdom, is pioneering the development of inhaled medicines for the targeted treatment of life-threatening respiratory diseases. Their core focus is on serious respiratory fungal infections, particularly pulmonary aspergi...
Also comparing in this category
Comparing more than these two?
Get Microbion Corporation, Pulmocide and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Microbion Corporation compare?
A PDF of Microbion Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Microbion Corporation with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Microbion Corporation on 27 Oct 2024, and Pulmocide on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
